Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis

PURPOSE: Cancer stem cells have recently been identified as a key driving factor for tumor metastasis and chemoresistance. CD117 is a well-established cancer stem cell marker, but its clinical significance in epithelial ovarian cancer (EOC) remains controversial. Therefore, we aimed to identify corr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Bikang, Yan, Xuebing, Liu, Liguo, Jiang, Chunyu, Hou, Shuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476715/
https://www.ncbi.nlm.nih.gov/pubmed/28652777
http://dx.doi.org/10.2147/OTT.S136549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476715/
https://www.ncbi.nlm.nih.gov/pubmed/28652777
http://dx.doi.org/10.2147/OTT.S136549

Ejemplares similares